-
Original Article
July 31, 2026
- Frequent Genetic Alterations in Metastatic Prostate Cancer Revealed by Targeted Sequencing
- Seung-Hwan Jeong, Jang Hee Han, Hyeong Dong Yuk, et al.
- J Urol Oncol. 2026;24(2):101-108.
-
Original Article
July 31, 2026
- GATA6 Alteration as a Potential Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated With Docetaxel After Androgen Receptor Pathway Inhibitor Failure
- Ja Yoon Heo, Chung Lee, Heesun Shin, et al.
- J Urol Oncol. 2026;24(2):109-118.
-
Original Article
July 31, 2026
- Expression of Phosphatase-Tensin Homolog and Erythroblast Transformation-Specific Related Genes in Prostate Carcinoma Cases Seen at Osun State University Teaching Hospital, Osogbo, Osun State, Nigeria: A 5-Year Retrospective Observational Study
- Olujuwon Towoju, Ganiat Omoniyi-Esan, Akinwumi Komolafe, et al.
- J Urol Oncol. 2026;24(2):119-126.
-
Original Article
July 31, 2026
- Lesion Volume Dynamics Add Prognostic Value Beyond Prostate Imaging Reporting and Data System Score Increase for Predicting Confirmatory Biopsy Upgrade During Active Surveillance
- Theodoros Karanikolas, Jonah Tripp, Morgan Joseph, et al.
- J Urol Oncol. 2026;24(2):127-136.
-
Brief Report
July 31, 2026
- Long-term Follow-up After Prostate-Specific Antigen Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
- Eric A. Miller, Paul F. Pinsky
- J Urol Oncol. 2026;24(2):137-141.
-
Brief Report
July 31, 2026
- Prostate-Specific Antigen Surveillance Rates in Sexual Minority Prostate Cancer Survivors During the COVID-19 Pandemic
- Ryan Haggart, Alex J. Bates, Badrinath R. Konety, et al.
- J Urol Oncol. 2026;24(2):142-146.
-
Original Article
July 31, 2026
- Integrated Immunophenotypic Stratification of Urothelial Carcinoma Using CK14, FOXA1, and p16: Correlation With Clinicopathological Features and Patient Outcomes
- Mona Saeed Mohammed, Nashaat Mohammed Salama
- J Urol Oncol. 2026;24(2):147-157.
-
Brief Report
July 31, 2026
- Specificity of a Urine-Based PENK Methylation Test (EarlyTect Bladder Cancer) in Patients With Benign Urologic Conditions and Healthy Controls
- Sang Hun Song, Sangchul Lee
- J Urol Oncol. 2026;24(2):158-161.
-
Original Article
July 31, 2026
- Retrospective Cohort Study Evaluating the Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Tyrosine Kinase Inhibitor-Associated Toxicity in Advanced Renal Cell Carcinoma
- Theodore Joseph Miller, Junjia Zhu, Megan Wheelden, et al.
- J Urol Oncol. 2026;24(2):162-171.
-
Review Article
July 31, 2026
- Updates on Renal Mass Ablation
- Simon Roh, Peter Lee
- J Urol Oncol. 2026;24(2):172-181.
-
Letter to the Editor
July 31, 2026
- A Commentary on “Radical Nephrectomy and Thrombectomy Without Cardiopulmonary Bypass for Level IV Venous Thrombus Renal Cell Carcinoma: Feasibility and Technical Tips”
- Matthew Gaynor, Gaetano Ciancio
- J Urol Oncol. 2026;24(2):182-183.
This archive contains links to the full-text of all issues.
Current issue
|
All issues
-
-
Journal of
Urologic OncologyPrint ISSN: 2951-603X
Online ISSN: 2982-7043
-
-
-
-
-
-
-
-
-
11,240 Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma 11,010 Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians 8,435 Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients 7,634 The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer 7,210 Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
Cited By
11Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion Cited By
8Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer Cited By
7Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review Cited By
5Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians Cited By
5Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
-
- Editorial Office
-
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.orgKorean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac
Copyright © The Korean Urological Oncology Society.
